Literature DB >> 7672493

Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland Study Group.

M Hiltunen1, H Hyöty, J Karjalainen, P Leinikki, M Knip, R Lounamaa, H K Akerblom.   

Abstract

To study the possible temporal association between primary cytomegalovirus infection and the appearance of islet cell autoantibodies or the development of insulin-dependent diabetes mellitus (IDDM) cytomegalovirus antibodies were analysed from follow-up sera of 46 initially non-diabetic siblings of diabetic children who either manifested clinical IDDM (22 siblings) or turned islet cell antibody positive (24 siblings) during the prospective observation (mean follow-up time 2.9 years). Secondly, cytomegalovirus antibodies were analysed during pregnancy in 96 mothers whose child presented with IDDM before the age of 7 years and in 96 control mothers who gave birth to a non-diabetic child. Thirdly, a case-control series including 90 newly-diagnosed young children with IDDM and their 90 control subjects was analysed. No seroconversions were found in cytomegalovirus antibodies during the follow-up of the 46 siblings indicating no temporal association with islet cell antibody seroconversion or manifestation of clinical diabetes. During the follow-up 17 (37%) siblings were constantly seronegative and 29 (63%) seropositive for cytomegalovirus IgG and there was no difference between islet cell antibody positive and negative siblings. Cytomegalovirus IgG and IgM were not different in pregnant mothers who gave birth to a subsequently diabetic child compared to control mothers, or in newly-diagnosed diabetic children compared to control children. Cytomegalovirus IgA was higher in newly-diagnosed diabetic children than in control children (p < 0.005). This difference disappeared when only cytomegalovirus IgG positive individuals were analysed. No correlation was found between islet cell antibodies and cytomegalovirus antibodies in newly-diagnosed diabetic patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672493     DOI: 10.1007/bf00401843

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.

Authors:  M Knip; P Vähäsalo; J Karjalainen; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

2.  Congenital cytomegalovirus infection and diabetes.

Authors:  K P Ward; W H Galloway; I A Auchterlonie
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

3.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

5.  Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.

Authors:  J E Banatvala; J Bryant; G Schernthaner; M Borkenstein; E Schober; D Brown; L M De Silva; M A Menser; M Silink
Journal:  Lancet       Date:  1985-06-22       Impact factor: 79.321

6.  Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.

Authors:  N K Blackburn; T G Besselaar; B D Schoub; K F O'Connell
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

7.  Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population.

Authors:  G Pagano; P Cavallo-Perin; F Cavalot; A M Dall'Omo; P Masciola; R Suriani; A Amoroso; S E Curtoni; I Borelli; G Lenti
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

8.  The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus.

Authors:  S A Ivarsson; B Lindberg; K O Nilsson; K Ahlfors; L Svanberg
Journal:  Diabet Med       Date:  1993-07       Impact factor: 4.359

9.  Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection.

Authors:  P D Griffiths; S Stagno; R F Pass; R J Smith; C A Alford
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

10.  Pancreatic islet-cell damage in children with fatal viral infections.

Authors:  A B Jenson; H S Rosenberg; A L Notkins
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

View more
  6 in total

Review 1.  Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.

Authors:  Mikael Knip
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  Prevention or acceleration of type 1 diabetes by viruses.

Authors:  Liana Ghazarian; Julien Diana; Yannick Simoni; Lucie Beaudoin; Agnès Lehuen
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

3.  Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes.

Authors:  J Aarnisalo; R Veijola; R Vainionpää; O Simell; M Knip; J Ilonen
Journal:  Diabetologia       Date:  2008-02-16       Impact factor: 10.122

4.  Maternal infection during pregnancy and type 1 diabetes mellitus in offspring: a systematic review and meta-analysis.

Authors:  Y Yue; Y Tang; J Tang; J Shi; T Zhu; J Huang; X Qiu; Y Zeng; W Li; Y Qu; D Mu
Journal:  Epidemiol Infect       Date:  2018-08-28       Impact factor: 4.434

Review 5.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

Review 6.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.